April 23-29, 2017 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 23-29, 2017 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
Last night, the FDA approved Ocrelizumab to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by…
The Rocky Mountain MS Center’s MS Young Professionals Network (MSYPN) is starting to grow! The mission of MSYPN is to provide an opportunity for young professionals to support the work…
Social Security has issued important new regulations which will go into effect for applications filed on or after March 27, 2017. These regulations, in most cases, may make it harder…
The connection between multiple sclerosis and vitamin D levels is an area of study that has long been of interest to researchers and people who are living with MS. A…
Earlier this fall, PCORI (the Patient Centered Outcomes Research Institute) released a request for funding applications for comparative effectiveness studies of Multiple sclerosis (MS) disease modifying therapies (DMTs). This includes…
We have an update for you regarding Ocrelizumab – the investigational disease modifying therapy that we have told you about over the past several months. Last week, the FDA…
Get Ready for Ski Season with Adaptive Ski Passes! The snow has started falling in the mountains and ski season is beginning here in the Rockies! If you are a…
Diane Kuehnast is swimming the English Channel many times over. But she avoids the cold, treacherous waters. Twice per week, Diane swims in the pools at the Englewood Recreation…